Year-over-year earnings per share growth for the last twelve months: sanaramedtech.com (SMTI)

Sanara MedTech (SMTI) - corporate logo

The quarterly EPS dynamics illustrate the financial trend of Sanara MedTech Inc. (SMTI), where the current level stands at approximately 95.70. Profit growth is driven by alliances with clinics to implement biomaterials. The company's competitive advantage is powered by innovative matrices that accelerate tissue regeneration. Expansion relies on organic sales growth and the strategic acquisition of rights to advanced gels from laboratories.

sanaramedtech.com (SMTI) Year-over-year net earnings per share change for the last twelve months: for the period 07/04/2022 - 11/16/2026

Comprehensive metric breakdowns and analytics for sanaramedtech.com (SMTI)

- share price and expert price forecast:
- company stock exchange capitalization indicators:
Initial company analysis:Sanara MedTech Inc.
Manufactured product of Sanara MedTech Inc.

Quarterly EPS growth measures the dynamics of net profit per share, reflecting the actual efficiency of capital management. This metric enables portfolio stress testing by identifying the business model's resilience to market volatility. By analyzing the current quarterly EPS growth value, an investor assesses the pace of profit scaling. For Sanara MedTech Inc. (SMTI), this confirms the operation of operating leverage. The expansion of the partner clinic network optimizes logistics, increasing overall profitability.

Who Sanara MedTech Inc. competes with

KRYS: Quarterly EPS earnings growth|APGE - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Arcutis Biotherapeutics, Inc.|Year-over-year earnings per share growth for the last 12 months VCEL (Vericel)|Year-over-year earnings per share growth for the last twelve months Oruka Pharma (ORKA)|DBV Technologies - Year-over-year earnings per share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Solesence SLSN|journeymedicalcorp.com (DERM) - Earnings per share growth in annualized terms for the last twelve months|FBRX - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share trend for the last twelve months EMPG|SLGL (sol-gel.com) - Year-over-year net earnings per share growth for the last 12 months|AXIL (AXIL Brands, Inc.) - Year-over-year earnings per share growth for the last twelve months|MDCX (Medicus Pharma Corp) - Quarterly EPS earnings growth|Verrica Pharmaceuticals (VRCA) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months HOTH (Hoth Therapeutics, Inc.)|BFRI - Earnings per share growth in annualized terms for the last twelve months|Quarterly EPS earnings growth VYNE (VYNE Therapeutics)|Year-over-year earnings per one share growth for the last 12 months SNOA|Quoin Pharmaceuticals Ltd. - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months Azitra Corporation AZTR|DRMA (Dermata) - Year-over-year net earnings per share growth for the last 12 months|Elevai Labs Inc. (ELAB) - Quarterly EPS earnings growth|RVNC (Revance Therapeutics, Inc.) - Quarterly EPS earnings growth